A Slow- Compared with a Fast-Release Form of Oral Arginine Increases Its Utilization for Nitric Oxide Synthesis in Overweight Adults with Cardiometabolic Risk Factors in a Randomized Controlled Study [Nutrient Physiology, Metabolism, and Nutrient-Nutrient Interactions]

Conclusion: In overweight adults with the HTW phenotype, a slow- compared with a fast-release form of oral arginine markedly favors the utilization of arginine for NO synthesis. The utilization of low-dose, slow-release arginine for NO synthesis is higher in overweight adults with the HTW phenotype than in healthy controls, suggesting that the sensitivity of NO synthesis to the dietary arginine supply increases with cardiometabolic risk. The trial was registered at clinicaltrials.gov as NCT02352740.

Source: Journal of Nutrition - June 30, 2016 Category: Nutrition Authors: Deveaux, A., Fouillet, H., Petzke, K. J., Hermier, D., Andre, E., Bunouf, P., Lantoine-Adam, F., Benamouzig, R., Mathe, V., Huneau, J.-F., Mariotti, F. Tags: Nutrient Physiology, Metabolism, and Nutrient-Nutrient Interactions Source Type: research